Vetmab Biosciences
PrivateLast Round
Early Funding
Apr 9, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vetmab Biosciences is a biotechnology company that develops monoclonal antibody therapeutics for dogs and cats.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetmab Biosciences Comparables
Compare Vetmab Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vetigenics Inc. | 83% | |
| Dechra Pharmaceuticals Limited | 77% | |
| Ceva Santé Animale | 77% | |
Vetmab Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 9, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 47% MoM.
- Apr 15, 2026
Monthly visitors grew 49% MoM, from 640 to 954.
Vetmab Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vetmab Biosciences's valuation, stock price, and market status.